Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Intraarticular expression of biologically-active interleukin-1 receptor-antagonist protein by ex-vivo gene-transfer

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Bandara, G.
  • Mueller, G. M.
  • Galealauri, J.
  • Tindal, M. H.
  • Georgescu, H. I.
  • Suchanek, M. K.
  • Hung, G. L.
  • Glorioso, J. C.
  • Robbins, Paul D.
  • Evans, C. H.

publication date

  • November 1993

journal

  • Proceedings of the National Academy of Sciences of the United States of America  Journal

abstract

  • Gene therapy offers a radical different approach to the treatment of arthritis. Here we have demonstrated that two marker genes (lacZ and neo) and cDNA coding for a potentially therapeutic protein (human interleukin 1-receptor-antagonist protein; IRAP or IL-1ra) can be delivered, by ex vivo techniques, to the synovial lining of joints; intraarticular expression of IRAP inhibited intraarticular responses to interleukin 1. To achieve this, lapine synoviocytes were first transduced in culture by retroviral infection. The genetically modified synovial cells were then transplanted by intraarticular injection into the knee joints of rabbits, where they efficiently colonized the synovium. Assay of joint lavages confirmed the in vivo expression of biologically active human IRAP. With allografted cells, IRAP expression was lost by 12 days after transfer. In contrast, autografted synoviocytes continued to express IRAP for approximately 5 weeks. Knee joints expressing human IRAP were protected from the leukocytosis that otherwise follows the intraarticular injection of recombinant human interleukin 1 beta. Thus, we report the intraarticular expression and activity of a potentially therapeutic protein by gene-transfer technology; these experiments demonstrate the feasibility of treating arthritis and other joint disorders with gene therapy.

subject areas

  • Animals
  • Arthritis
  • Cloning, Molecular
  • Gene Expression
  • Gene Transfer Techniques
  • Genetic Therapy
  • Humans
  • Injections, Intra-Articular
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-1
  • RNA, Messenger
  • Rabbits
  • Sialoglycoproteins
  • Synovial Membrane
  • Transfection
scroll to property group menus

Research

keywords

  • ARTHRITIS
  • CELL TRANSPLANTATION
  • GENE THERAPY
scroll to property group menus

Identity

PubMed Central ID

  • PMC47858

International Standard Serial Number (ISSN)

  • 0027-8424

Digital Object Identifier (DOI)

  • 10.1073/pnas.90.22.10764

PubMed ID

  • 8248169
scroll to property group menus

Additional Document Info

start page

  • 10764

end page

  • 10768

volume

  • 90

issue

  • 22

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support